308 related articles for article (PubMed ID: 36754426)
1. Maternal mRNA covid-19 vaccination during pregnancy and delta or omicron infection or hospital admission in infants: test negative design study.
Jorgensen SCJ; Hernandez A; Fell DB; Austin PC; D'Souza R; Guttmann A; Brown KA; Buchan SA; Gubbay JB; Nasreen S; Schwartz KL; Tadrous M; Wilson K; Kwong JC;
BMJ; 2023 Feb; 380():e074035. PubMed ID: 36754426
[TBL] [Abstract][Full Text] [Related]
2. Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes.
Buchan SA; Chung H; Brown KA; Austin PC; Fell DB; Gubbay JB; Nasreen S; Schwartz KL; Sundaram ME; Tadrous M; Wilson K; Wilson SE; Kwong JC
JAMA Netw Open; 2022 Sep; 5(9):e2232760. PubMed ID: 36136332
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study.
Grewal R; Kitchen SA; Nguyen L; Buchan SA; Wilson SE; Costa AP; Kwong JC
BMJ; 2022 Jul; 378():e071502. PubMed ID: 35793826
[TBL] [Abstract][Full Text] [Related]
4. Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a test-negative case-control study.
Tartof SY; Slezak JM; Puzniak L; Hong V; Xie F; Ackerson BK; Valluri SR; Jodar L; McLaughlin JM
Lancet Respir Med; 2022 Jul; 10(7):689-699. PubMed ID: 35468336
[TBL] [Abstract][Full Text] [Related]
5. mRNA SARS-CoV-2 Vaccination Before vs During Pregnancy and Omicron Infection Among Infants.
Goh O; Pang D; Tan J; Lye D; Chong CY; Ong B; Tan KB; Yung CF
JAMA Netw Open; 2023 Nov; 6(11):e2342475. PubMed ID: 37948079
[TBL] [Abstract][Full Text] [Related]
6. Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants.
Halasa NB; Olson SM; Staat MA; Newhams MM; Price AM; Pannaraj PS; Boom JA; Sahni LC; Chiotos K; Cameron MA; Bline KE; Hobbs CV; Maddux AB; Coates BM; Michelson KN; Heidemann SM; Irby K; Nofziger RA; Mack EH; Smallcomb L; Schwartz SP; Walker TC; Gertz SJ; Schuster JE; Kamidani S; Tarquinio KM; Bhumbra SS; Maamari M; Hume JR; Crandall H; Levy ER; Zinter MS; Bradford TT; Flori HR; Cullimore ML; Kong M; Cvijanovich NZ; Gilboa SM; Polen KN; Campbell AP; Randolph AG; Patel MM;
N Engl J Med; 2022 Jul; 387(2):109-119. PubMed ID: 35731908
[TBL] [Abstract][Full Text] [Related]
7. Vaccine effectiveness and duration of protection of COVID-19 mRNA vaccines against Delta and Omicron BA.1 symptomatic and severe COVID-19 outcomes in adults aged 50 years and over in France.
Tamandjou Tchuem CR; Auvigne V; Vaux S; Montagnat C; Paireau J; Monnier Besnard S; Gabet A; Benhajkassen N; Le Strat Y; Parent Du Chatelet I; Levy-Bruhl D
Vaccine; 2023 Mar; 41(13):2280-2288. PubMed ID: 36870880
[TBL] [Abstract][Full Text] [Related]
8. Newborn and Early Infant Outcomes Following Maternal COVID-19 Vaccination During Pregnancy.
Jorgensen SCJ; Drover SSM; Fell DB; Austin PC; D'Souza R; Guttmann A; Buchan SA; Wilson SE; Nasreen S; Schwartz KL; Tadrous M; Wilson K; Kwong JC
JAMA Pediatr; 2023 Dec; 177(12):1314-1323. PubMed ID: 37870875
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.
Nyberg T; Ferguson NM; Nash SG; Webster HH; Flaxman S; Andrews N; Hinsley W; Bernal JL; Kall M; Bhatt S; Blomquist P; Zaidi A; Volz E; Aziz NA; Harman K; Funk S; Abbott S; ; Hope R; Charlett A; Chand M; Ghani AC; Seaman SR; Dabrera G; De Angelis D; Presanis AM; Thelwall S
Lancet; 2022 Apr; 399(10332):1303-1312. PubMed ID: 35305296
[TBL] [Abstract][Full Text] [Related]
10. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
[TBL] [Abstract][Full Text] [Related]
11. Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States.
Schrag SJ; Verani JR; Dixon BE; Page JM; Butterfield KA; Gaglani M; Vazquez-Benitez G; Zerbo O; Natarajan K; Ong TC; Lazariu V; Rao S; Beaver R; Ellington SR; Klein NP; Irving SA; Grannis SJ; Kiduko S; Barron MA; Midturi J; Dickerson M; Lewis N; Stockwell MS; Stenehjem E; Fadel WF; Link-Gelles R; Murthy K; Goddard K; Grisel N; Valvi NR; Fireman B; Arndorfer J; Konatham D; Ball S; Thompson MG; Naleway AL
JAMA Netw Open; 2022 Sep; 5(9):e2233273. PubMed ID: 36156146
[TBL] [Abstract][Full Text] [Related]
12. Association of COVID-19 Vaccination During Pregnancy With Incidence of SARS-CoV-2 Infection in Infants.
Carlsen EØ; Magnus MC; Oakley L; Fell DB; Greve-Isdahl M; Kinge JM; Håberg SE
JAMA Intern Med; 2022 Aug; 182(8):825-831. PubMed ID: 35648413
[TBL] [Abstract][Full Text] [Related]
13. Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study.
Lauring AS; Tenforde MW; Chappell JD; Gaglani M; Ginde AA; McNeal T; Ghamande S; Douin DJ; Talbot HK; Casey JD; Mohr NM; Zepeski A; Shapiro NI; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Exline MC; Gong MN; Mohamed A; Johnson NJ; Srinivasan V; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; Gordon AJ; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Halasa N; Grijalva CG; Rice TW; Stubblefield WB; Baughman A; Womack KN; Rhoads JP; Lindsell CJ; Hart KW; Zhu Y; Adams K; Schrag SJ; Olson SM; Kobayashi M; Verani JR; Patel MM; Self WH;
BMJ; 2022 Mar; 376():e069761. PubMed ID: 35264324
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of Maternal mRNA COVID-19 Vaccination During Pregnancy Against COVID-19-Associated Hospitalizations in Infants Aged <6 Months During SARS-CoV-2 Omicron Predominance - 20 States, March 9, 2022-May 31, 2023.
Simeone RM; Zambrano LD; Halasa NB; Fleming-Dutra KE; Newhams MM; Wu MJ; Orzel-Lockwood AO; Kamidani S; Pannaraj PS; Irby K; Maddux AB; Hobbs CV; Cameron MA; Boom JA; Sahni LC; Kong M; Nofziger RA; Schuster JE; Crandall H; Hume JR; Staat MA; Mack EH; Bradford TT; Heidemann SM; Levy ER; Gertz SJ; Bhumbra SS; Walker TC; Bline KE; Michelson KN; Zinter MS; Flori HR; Campbell AP; Randolph AG;
MMWR Morb Mortal Wkly Rep; 2023 Sep; 72(39):1057-1064. PubMed ID: 37874864
[TBL] [Abstract][Full Text] [Related]
15. Coronavirus Disease 19 (COVID-19) Vaccine Effectiveness Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During Delta-Dominant and Omicron-Dominant Periods in Japan: A Multicenter Prospective Case-control Study (Factors Associated with SARS-CoV-2 Infection and the Effectiveness of COVID-19 Vaccines Study).
Arashiro T; Arima Y; Muraoka H; Sato A; Oba K; Uehara Y; Arioka H; Yanai H; Kuramochi J; Ihara G; Chubachi K; Yanagisawa N; Nagura Y; Kato Y; Ueda A; Numata A; Kato H; Ishii K; Ooki T; Oka H; Nishida Y; Stucky A; Smith C; Hibberd M; Ariyoshi K; Suzuki M
Clin Infect Dis; 2023 Feb; 76(3):e108-e115. PubMed ID: 35918782
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study.
Chung H; He S; Nasreen S; Sundaram ME; Buchan SA; Wilson SE; Chen B; Calzavara A; Fell DB; Austin PC; Wilson K; Schwartz KL; Brown KA; Gubbay JB; Basta NE; Mahmud SM; Righolt CH; Svenson LW; MacDonald SE; Janjua NZ; Tadrous M; Kwong JC;
BMJ; 2021 Aug; 374():n1943. PubMed ID: 34417165
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Maternal Inactivated COVID-19 Vaccination against Omicron Infection in Infants during the First 12 Months of Life: A Test-Negative Case-Control Study.
Zhong J; Wang W; Liu S; Chen Y; Xiong H; Meng X; Zhang D; Ma Y
Vaccines (Basel); 2023 Aug; 11(9):. PubMed ID: 37766080
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy outcomes after SARS-CoV-2 infection in periods dominated by delta and omicron variants in Scotland: a population-based cohort study.
Stock SJ; Moore E; Calvert C; Carruthers J; Denny C; Donaghy J; Hillman S; Hopcroft LEM; Hopkins L; Goulding A; Lindsay L; McLaughlin T; Taylor B; Auyeung B; Katikireddi SV; McCowan C; Ritchie LD; Rudan I; Simpson CR; Robertson C; Sheikh A; Wood R
Lancet Respir Med; 2022 Dec; 10(12):1129-1136. PubMed ID: 36216011
[TBL] [Abstract][Full Text] [Related]
19. Estimated Effectiveness of Postpartum Maternal Messenger RNA COVID-19 Vaccination Against Delta and Omicron SARS-CoV-2 Infection and Hospitalization in Infants Younger Than 6 Months.
Jorgensen SCJ; Hernandez A; Fell DB; Austin PC; D'Souza R; Guttmann A; Kwong JC
JAMA Pediatr; 2023 Apr; 177(4):427-430. PubMed ID: 36848130
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study.
Bruxvoort KJ; Sy LS; Qian L; Ackerson BK; Luo Y; Lee GS; Tian Y; Florea A; Aragones M; Tubert JE; Takhar HS; Ku JH; Paila YD; Talarico CA; Tseng HF
BMJ; 2021 Dec; 375():e068848. PubMed ID: 34911691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
